Relapse prevention among schizophrenia: A multi stage randomised controlled group study.
| ISRCTN | ISRCTN20556456 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN20556456 |
| Protocol serial number | N0195129515 |
| Sponsor | Department of Health |
| Funder | London West Mental R&D Consortium (UK) |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 29/05/2012
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Rami Jumnoodoo
Scientific
Scientific
Trust
Park Royal MH Centre
Twyford Centre
Acton lane
Central Way
London
NW10 7NS
United Kingdom
| Phone | +44 (0)208 453 2779 |
|---|---|
| rami.jumnoodoo@nhs.net |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | |
| Study objectives | Whether a prescribed course of relapse prevention therapy (RPT), based on Marlatts model, may have a statistically significant higher knowledge score post-group; whether there will be a significant reduction of inpatient bed nights and whether there will be a statistically significant degree of contact maintenance with helping services by comparison with the comparison group? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Mental and Behavioural Disorders: Schizophrenia |
| Intervention | For the experimental group, there will be a semi structured interview questionnaire at pre and post relapse prevention therapy (RPT) and at 5 weeks follow up. For the control group, there will be a semi structured questionnaire to be completed at the same time as that of the experimental group and afterwards at 3 months interval to ensure matching time intervals. In addition there will be a demographic characteristic form to complete on ever participant. |
| Intervention type | Other |
| Primary outcome measure(s) |
Relapse prevention skills and knowledge, reduction of in-patient hospitalisation and an improvement in maintaining contact with helping services. |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 16/06/2003 |
| Reason abandoned (if study stopped) | Lack of staff/facilities/resources |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Key inclusion criteria | Patients with a primary diagnosis of schizophrenia (International Statistical Classification of Diseases and Related Health Problems - tenth revision [ICD10] = F20-29) |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 08/07/2002 |
| Date of final enrolment | 16/06/2003 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Trust
London
NW10 7NS
United Kingdom
NW10 7NS
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
